RALEIGH – North Carolina-based MAKO Medical Laboratories has announced the launch of its new COVflu-19™ test. A national leader in virus testing, MAKO officials said Wednesday that this one test will allow for the detection of SARS-CoV-2 (COVID-19), Influenza A, and Influenza B from a single swab.
“Rapid, reliable turnaround times have set MAKO Medical apart,” said Josh Arant, COO, MAKO Medical. “COVflu-19™ will provide the information needed to help monitor the spread of COVID-19 and the flu, two respiratory viruses with very similar clinical symptoms.”
MAKO, a College of American Pathologists accredited laboratory, will process COVflu-19™ on the same real-time PCR instruments that it uses for COVID-19 results. Company officials say that this will allow the MAKO team to provide reliable test results within 24 to 48 hours upon receipt in the MAKO laboratory.
“We know people are anxious about the upcoming flu season,” said Arant. “We want to help ease their fears by assisting health care providers promptly and properly diagnose symptoms. We view this as an opportunity to serve one another during a challenging time in our country.”
Since April, MAKO Medical has been serving in a critical COVID-19 response role. The team transitioned from providing traditional lab services to focusing on COVID-19 tests, and over the past seven months, has processed more than 1.7 million COVID-19 tests across 20+ states for medical providers, employers and governments.
